目的:评估通过TruClear™宫腔镜机械切除子宫内膜息肉和粘膜下肌瘤患者的疗效。
方法:描述性研究。研究的地点和持续时间:妇产科,希法国际医院,伊斯兰堡,巴基斯坦,从2018年6月到2022年。
方法:纳入经腹部或阴道超声检查确诊为子宫内膜息肉和粘膜下肌瘤的患者。有充血性心力衰竭病史的患者,慢性肾病,出血素质被排除在研究之外.关于完全切除病理(子宫内膜息肉和粘膜下肌瘤)的数据,平均运行时间,术后出血、穿孔等并发症。随访时间为手术后6个月。
结果:45例患者的平均年龄为35.62±7.46岁。月经大出血是最常见的症状,在73.3%的病例中,其次是不规则阴道出血(IVB)在11.1%的病例。通过超声检查确定的最常见的疾病是21例(47%)息肉,其次是12例(27%)粘膜下肌瘤,混合病理10例(22%),和恶性肿瘤2例(4%)。总体平均手术时间为36.46±24.94分钟。在该研究中观察到100%的损伤去除。13%的患者在手术后观察到持续症状,因此他们接受了其他干预措施。最常见的干预是子宫内激素装置。仅在一名患者中观察到术中出血,并通过术中子宫内球囊插入进行管理。复发率为8.9%(4/45)。
结论:TruClear™宫腔镜在成功和完全切除病理方面显示出主要优势,低运行时间,和并发症。
背景:纤维,宫腔镜检查,息肉,子宫内膜切除术,月经出血.
OBJECTIVE: To assess the efficacy of mechanical resection through TruClear™
hysteroscopy in patients with endometrial polyps and submucosal fibroids.
METHODS: Descriptive study. Place and Duration of the Study: Department of Obstetrics and Gynaecology, Shifa International Hospital, Islamabad, Pakistan, from June 2018 to 2022.
METHODS: Patients diagnosed with endometrial polyps and submucosal fibroids confirmed by abdominal or transvaginal ultrasonography were included. Patients having a history of congestive cardiac failure, chronic kidney disease, and bleeding diathesis were excluded from the study. Data about the complete removal of pathology (endometrial polyps and submucosal fibroids), mean operating time, and postoperative complications such as bleeding and perforation were extracted. The follow-up was set up to 6 months after the procedure.
RESULTS: The average age of the 45 patients was 35.62 ± 7.46 years. Heavy menstrual bleeding was the most prevalent symptom, seen in 73.3% of cases, followed by irregular vaginal bleeding (IVB) in 11.1% of cases. The most frequent disease identified by sonography was a polyp in 21 (47%) instances, followed by submucosal fibroids in 12 (27%) cases, mixed pathology in 10 (22%), and malignancy in 2 (4%) cases. The overall average operative time was 36.46 ± 24.94 minutes. A hundred percent removal of lesions was observed in this study. Persistent symptoms were observed in 13% of patients after the surgery so they were treated with other interventions. The most common intervention was an intrauterine hormonal device. Intraoperative bleeding was observed in only one patient and was managed by intraoperative intrauterine balloon insertion. The recurrence rate was 8.9% (4/45).
CONCLUSIONS: TruClear™
hysteroscopy showed a major advantage in the successful and complete removal of the pathology, low operation time, and complications.
BACKGROUND: Fibroids,
Hysteroscopy, Polyps, Endometrial resection, Menstrual bleeding.